The present experiments were designed to study the effect of adding the detergent Equex-STM to freezing extender, and of straw volume (0.25 ml vs 0.5 ml), on boar sperm quality after cryopreservation. Three ejaculates from each of four purebred boars (three Landrace and one Yorkshire) were collected and frozen with a lactose-egg yolk extender containing glycerol with or without 1.5% Equex-STM. The extended semen was loaded into either 0.25- or 0.5-ml straws. The straws were placed in liquid nitrogen (LN(2)) vapour approximately 3 cm above the level of LN(2) for 20 min and then were plunged into LN(2). Thawing was achieved in warm water at 50 degrees C for 12 s and then was incubated in a 38 degrees C water-bath for 30 min before evaluating sperm quality. Results showed that the individual motility, viability and acrosomal normal apical ridge (NAR) were improved (p < 0.001) when Equex-STM was added to the freezing extender. There was no difference (p = 0.48) in sperm motility between 0.25- and 0.5-ml straws when Equex-STM was added. The percentages of viable and of NAR sperm in 0.5-ml straws were higher than those in 0.25-ml straws (p = 0.02, p = 0.0003 respectively). The percentages of membrane intact sperm evaluated using the short hypo-osmotic swelling test were not affected by straw volume or the adding of Equex-STM (p > 0.05). The results of these investigations suggested that Equex-STM exerts a beneficial effect on the quality of cryopreserved boar semen and this cryopreservation protocol was favourable for a 0.5-ml straw.

No abstract

No abstract

The aim of the present study was to evaluate the control of ovulation by the administration of human chorionic gonadotropin (hCG) or gonadotropin-releasing hormone (GnRH) at the onset of estrus. Thirty-three multiparous sows housed under tropical conditions and showing standing estrus within 5 days after weaning were included. The sows were allocated to three groups, spontaneous ovulation (control group, n = 10), induced ovulation using 750 IU hCG (hCG group, n = 10), and induced ovulation using 50 μg GnRH (GnRH group, n = 13). The hormones were given at the onset of estrus and the occurrence of ovulation was monitored every 6 h by transrectal ultrasonography. Data for weaning-to-estrus interval, onset of estrus-to-ovulation interval (EOI), and the length of estrus were recorded. All sows in the control and hCG groups ovulated, while 3 out of 13 sows treated with GnRH developed cystic ovaries (did not ovulate). Of those sows ovulating, the EOI of the hCG (40.2 ± 1.7 h) and GnRH (37.5 ± 3.3 h) groups were shorter than that of the control group (63.6 ± 9.6 h; P < 0.05). In conclusion, the administration of either hCG or GnRH at the onset of estrus can control time of ovulation but, at the dose employed, sows receiving GnRH may develop ovarian cysts.